ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CRISPR And CRISPR-Associated (Cas) Genes Market Consumption Analysis, Growth Forecast by Manufacturers … – Medgadget (blog)

CRISPR And CRISPR-Associated (Cas) Genes Market Consumption Analysis, Growth Forecast by Manufacturers …Medgadget (blog)CRISPR And CRISPR-Associated (Cas) Genes Market is expected to witness growth of international market with respect to advancements… Continue reading

2017-03-02 Michael Zand NEWS

CRISPR And CRISPR-Associated (Cas) Genes Market Consumption Analysis, Growth Forecast by Manufacturers … – Medgadget (blog)

CRISPR And CRISPR-Associated (Cas) Genes Market Consumption Analysis, Growth Forecast by Manufacturers …Medgadget (blog)CRISPR And CRISPR-Associated (Cas) Genes Market is expected to witness growth of international market with respect to advancements… Continue reading

2017-03-02 Michael Zand NEWS

Two adversaries in the CRISPR patent battle meet — and look ahead – STAT

Continue reading

2017-03-02 Michael Zand NEWS

Two adversaries in the CRISPR patent battle meet — and look ahead – STAT


STAT

Two adversaries in the CRISPR patent battle meet — and look ahead
STAT
Two of the leading adversaries in the battle to own CRISPR, the powerful gene-editing tool, took the stage together at a genetic medicine conference here, and they couldn’t have been more polite — or more forward-looking. This is a STAT Plus article …

Continue reading

2017-03-02 Michael Zand NEWS

Absent tumor-suppressors allow melanoma to thwart immunotherapy – Science Daily


STAT

Two adversaries in the CRISPR patent battle meet — and look ahead
STAT
Two of the leading adversaries in the battle to own CRISPR, the powerful gene-editing tool, took the stage together at a genetic medicine conference here, and they couldn’t have been more polite — or more forward-looking. This is a STAT Plus article …

Continue reading

2017-03-02 Michael Zand NEWS

Want more crop variety? Researchers propose using CRISPR to accelerate plant domestication – Science Daily

Absent tumor-suppressors allow melanoma to thwart immunotherapy
Science Daily
“That’s evidence that anti-CTLA4 in some cases primes T cells for the next step, anti-PD1 immunotherapy. It’s well known that if you don’t have T cells in the tumor, anti-PD1 won’t do anything, it doesn’t bring T cells into the tumor,” Futreal says …

and more »

Continue reading

2017-03-02 Michael Zand NEWS

Artificial embryo shows early potential for medical therapies, not babies – CNN

Want more crop variety? Researchers propose using CRISPR to accelerate plant domestication
Science Daily
But with CRISPR technology, we don’t have to wait for nature to help us domesticate plants, argue researchers at the University of Copenhagen. In a Review published March 2 in Trends in Plant Science, they describe how gene editing could make, for …

and more »

Continue reading

2017-03-02 Michael Zand NEWS

Round one of the the US CRISPR patent battle is over – but what does the PTABS’s no interference-in-fact decision … – JD Supra (press release)


CNN

Artificial embryo shows early potential for medical therapies, not babies
CNN
(CNN) Trying to mimic the early stages of reproduction, Cambridge University researchers cultivated two types of mouse stem cells in a Petri dish and watched an embryo emerge — one that closely resembled a natural mouse embryo in its architecture, …
Artificial embryo grown in a dish from two types of stem cellsNew Scientist
Cambridge scientists create first self-developing embryo from stem cellsThe Guardian
Scientists create artificial mouse ’embryo’ from stem cells for first timeScience Daily
The Scientist –TechRadar
all 82 news articles »
Continue reading

2017-03-02 Michael Zand NEWS
  • 1
  • …
  • 2,025
  • 2,026
  • 2,027
  • 2,028
  • 2,029
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Round one of the the US CRISPR patent battle is over – but what does the PTABS’s no interference-in-fact decision …
JD Supra (press release)
3 Cpf1 is a new type of Cas protein (Class 2 type V) which is able to be used in CRISPR-mediated gene editing in place of Cas9. Cpf1 has different characteristics to Cas9 which some think could give rise to a different range of applications for CRISPR …

and more »